K Matthew Fust

Affiliations

  • at Crinetics Pharmaceuticals Inc. (CRNX), 2025-06-13
  • at Atara Biotherapeutics Inc. (ATRA), 2025-06-13
  • at Neumora Therapeutics Inc. (NMRA), 2025-05-30
  • at Ultragenyx Pharmaceutical Inc. (RARE), 2025-05-19
  • at Dermira Inc. (DERM), 2020-02-25
  • Director at Macrogenics Inc (MGNX), 2019-05-20
  • Evp & Chief Financial Officer at Onyx Pharmaceuticals Inc (ONXX), 2013-10-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DERM $16.77 6,000 $100,604.40 6,000 2014-11-25 Filing
RARE $21.00 5,000 $105,000.00 5,000 2014-01-30 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NMRA $17.03 14,049 $239,319.10 20,100 2024-10-18 Filing
NMRA $17.01 7,739 $131,642.71 20,100 2024-10-17 Filing
CRNX $45.50 17,500 $796,250.00 18,536 2024-03-20 Filing
CRNX $43.58 17,500 $762,650.00 18,536 2024-03-20 Filing
CRNX $43.57 12,500 $544,625.00 18,536 2024-03-20 Filing